Title |
Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study
|
---|---|
Published in |
Journal of Pain Research, April 2013
|
DOI | 10.2147/jpr.s43395 |
Pubmed ID | |
Authors |
Lucinda Bateman, Robert H Palmer, Joel M Trugman, Yuhua Lin |
Abstract |
The purpose of this study was to evaluate the safety, tolerability, and efficacy of milnacipran following a direct switch from duloxetine in fibromyalgia patients experiencing inadequate clinical response to duloxetine after receiving treatment for 6 weeks or longer. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 75% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Science communicators (journalists, bloggers, editors) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 3% |
Unknown | 35 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 25% |
Other | 5 | 14% |
Student > Bachelor | 5 | 14% |
Student > Doctoral Student | 4 | 11% |
Student > Postgraduate | 3 | 8% |
Other | 7 | 19% |
Unknown | 3 | 8% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 47% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 11% |
Nursing and Health Professions | 4 | 11% |
Economics, Econometrics and Finance | 2 | 6% |
Social Sciences | 2 | 6% |
Other | 2 | 6% |
Unknown | 5 | 14% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2021.
All research outputs
#4,195,256
of 23,577,654 outputs
Outputs from Journal of Pain Research
#447
of 1,815 outputs
Outputs of similar age
#35,119
of 201,905 outputs
Outputs of similar age from Journal of Pain Research
#7
of 26 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,815 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,905 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.